EMEA and PIC/S announce collaboration
This article was originally published in The Gold Sheet
EMEA and the Pharmaceutical Inspection Cooperation Scheme have announced plans to strengthen their cooperation in the field of GMP inspections "with a view to sharing resources and avoiding the duplication of activities." To formalize these plans, the PIC/S chairman and the executive director of EMEA have signed a cooperation agreement in the form of an exchange of letters. The agreement covers areas of common interest, in particular the training of GMP inspectors, the exchange of information on guidance documents and audits of GMP inspectorates
You may also be interested in...
The US FDA released five device-related close-out letters in March.
Governments around the world should designate all medicines as ‘priority essential products’, the IGBA has urged, as a surge in demand coinciding with a reduction in the number of flights and rising freight costs are making it more difficult for suppliers to meet global requirements amid the coronavirus pandemic.
In a letter to the medtech industry, the FDA’s William Maisel says the US agency will hold remote meetings with device makers and other stakeholders through the end of May. The FDA also extended due dates for marketing applications by 90 days.